Nanotechnology Now - Press Release: "BIOIDENT Receives 2007 Frost & Sullivan Enabling Technology of the Year Award"

Home > Press > BIOIDENT Receives 2007 Frost & Sullivan Enabling Technology of the Year Award

Abstract:
Company's PhotonicLab Platform Recognized by Prominent Analyst Firm

BIOIDENT Receives 2007 Frost & Sullivan Enabling Technology of the Year Award

MENLO PARK, CA | Posted on May 8th, 2007

BIOIDENT Technologies Inc., the leading company in the development of printed optoelectronic solutions for life sciences, today announced that it is the recipient of the 2007 Frost & Sullivan Enabling Technology of the Year Award for its superior expertise in lab-on-a-chip technologies.

The distinguished award is presented to a company who has developed a solution that revolutionizes an industry and removes a significant stumbling block in the development of a technology. The award criteria also ensure that the enabling technology translates into a more efficient, cost-effective and portable alternative for end-users.

"We are honored to be chosen for this prestigious award that recognizes our revolutionary, disposable lab-on-a-chip platform, which sets new standards in the industry," said Dr. Wasiq Bokhari, CEO for BIOIDENT. "This acknowledgment validates BIOIDENT's expertise in integrating microfluidics and organic photonics into a single solution and exemplifies the wide ranging capabilities of the technology in applications such as point-of-care diagnostics, water and food analysis, and chemical and biological agent detection."

BIOIDENT utilizes breakthroughs in science and nanotechnology to develop printed optoelectronic solutions that take lab-on-a-chip devices to the next level by integrating an optoelectronic readout system into the chip. The company uses established testing protocols to deliver real-time and in-situ multi-parameter detection capabilities for all categories of chemical and biological analytes, which expands its applications.

"BIOIDENT's pioneering technology will transform the point-of-care-testing (POCT) and life science industry, especially as manufacturers seek devices that are user-friendly, provide superior test results and are available at a competitive price," explains Arun AK, analyst for Frost & Sullivan. "With the company's deep expertise, rapid production capability and innovative applications, BIOIDENT is poised to become a global leader in providing safe, breakthrough health care products."

For more information about BIOIDENT, the PhotonicLab™ Platform and PhotonicFlow™ System, please visit http://www.bioident.com .

####

About BIOIDENT Technologies Inc.
BIOIDENT is the technology leader in the development of printed semiconductor-based photonic lab-on-a-chip solutions for the life science market. The company’s core technology utilizes the latest breakthroughs in science and nanotechnology to create the PhotonicLab™ Platform. This platform is used to produce the world’s first disposable photonic lab-on-a-chip solutions for next generation mobile analytics applications such as water and food analysis, chemical and biological agent detection, and personal or in-the-field diagnostics.

BIOIDENT is a subsidiary of Austrian-based NANOIDENT Technologies AG.

The company is privately-held with headquarters in Menlo Park, Calif. BIOIDENT leverages NANOIDENT’s SEMICONDUCTOR 2.0™ Platform technology and its high-speed manufacturing process, which uses liquid conductive and semi-conductive materials to print electronic circuits on almost any surface using an inkjet printer.

For more information, please click here

Contacts:
Schwartz Communications
Alissa Vasilevskis or Carmen Pearson, +1-415-512-0770

or
BIOIDENT Technologies Inc.
+1-650-391-4248

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: